{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:21:28Z","timestamp":1785324088587,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04571-6","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:26:44Z","timestamp":1778552804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-6685","authenticated-orcid":false,"given":"Enrico","family":"Munari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Polati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cali\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Tinazzi Martini","family":"Gobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo G.","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Grisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Litjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"4571_CR1","doi-asserted-by":"publisher","first-page":"S477","DOI":"10.21037\/TAU.2018.02.06","volume":"7","author":"O Hassan","year":"2018","unstructured":"Hassan O, Matoso A (2018) Clinical significance of subtypes of Gleason pattern 4 prostate cancer. Transl Androl Urol 7:S477\u2013S483. https:\/\/doi.org\/10.21037\/TAU.2018.02.06","journal-title":"Transl Androl Urol"},{"key":"4571_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/PAS.0000000000000457","volume":"39","author":"M Zhou","year":"2015","unstructured":"Zhou M, Li J, Cheng L et al (2015) Diagnosis of Poorly Formed Glands Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol 39:1331\u20131339. https:\/\/doi.org\/10.1097\/PAS.0000000000000457","journal-title":"Am J Surg Pathol"},{"key":"4571_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/MODPATHOL.2016.49","volume":"29","author":"CF Kweldam","year":"2016","unstructured":"Kweldam CF, K\u00fcmmerlin IP, Nieboer D et al (2016) Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy. Mod Pathol 29:630\u2013636. https:\/\/doi.org\/10.1038\/MODPATHOL.2016.49","journal-title":"Mod Pathol"},{"key":"4571_CR4","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/MODPATHOL.2017.29","volume":"30","author":"CF Kweldam","year":"2017","unstructured":"Kweldam CF, K\u00fcmmerlin IP, Nieboer D et al (2017) Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3\u2009+\u20094=7 prostate cancer. Mod Pathol 30:1126\u20131132. https:\/\/doi.org\/10.1038\/MODPATHOL.2017.29","journal-title":"Mod Pathol"},{"key":"4571_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/S00428-015-1809-5","volume":"467","author":"DT Keefe","year":"2015","unstructured":"Keefe DT, Schieda N, El Hallani S et al (2015) Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3\u2009+\u20094\u2009=\u20097 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy. Virchows Arch 467:437\u2013442. https:\/\/doi.org\/10.1007\/S00428-015-1809-5","journal-title":"Virchows Arch"},{"key":"4571_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41391-022-00600-y","volume":"26","author":"GI Russo","year":"2023","unstructured":"Russo GI, Soeterik T, Puche-Sanz I et al (2023) Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 26:646\u2013654. https:\/\/doi.org\/10.1038\/s41391-022-00600-y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4571_CR7","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1097\/PAS.0b013e3182a02169","volume":"37","author":"F Dong","year":"2013","unstructured":"Dong F, Yang P, Wang C et al (2013) Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol 37:1855\u20131861. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a02169","journal-title":"Am J Surg Pathol"},{"key":"4571_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/J.EUF.2020.10.007","volume":"7","author":"Y Zong","year":"2021","unstructured":"Zong Y, Montironi R, Massari F et al (2021) Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives. Eur Urol Focus 7:955\u2013963. https:\/\/doi.org\/10.1016\/J.EUF.2020.10.007","journal-title":"Eur Urol Focus"},{"key":"4571_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/HIS.14216","volume":"78","author":"M Varma","year":"2021","unstructured":"Varma M, Epstein JI (2021) Head to head: should the intraductal component of invasive prostate cancer be graded? Histopathology 78:231\u2013239. https:\/\/doi.org\/10.1111\/HIS.14216","journal-title":"Histopathology"},{"key":"4571_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.EURURO.2019.07.051","volume":"77","author":"GJLH van Leenders","year":"2020","unstructured":"van Leenders GJLH, Kweldam CF, Hollemans E et al (2020) Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups. Eur Urol 77:191\u2013198. https:\/\/doi.org\/10.1016\/J.EURURO.2019.07.051","journal-title":"Eur Urol"},{"key":"4571_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/his.70046","volume":"88","author":"RB Shah","year":"2026","unstructured":"Shah RB, Varma M, Zhou M et al (2026) The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate. Histopathology 88:8\u201323. https:\/\/doi.org\/10.1111\/his.70046","journal-title":"Histopathology"},{"key":"4571_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/S41379-018-0157-9","volume":"32","author":"E Hollemans","year":"2019","unstructured":"Hollemans E, Verhoef EI, Bangma CH et al (2019) Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Mod Pathol 32:139\u2013146. https:\/\/doi.org\/10.1038\/S41379-018-0157-9","journal-title":"Mod Pathol"},{"key":"4571_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41379-022-01009-7","volume":"35","author":"E Chan","year":"2022","unstructured":"Chan E, McKenney JK, Hawley S et al (2022) Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25\u00a0mm diameter as an optimal definition for large cribriform prostatic adenocarcinoma. Mod Pathol 35:1092\u20131100. https:\/\/doi.org\/10.1038\/s41379-022-01009-7","journal-title":"Mod Pathol"},{"key":"4571_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/his.15231","volume":"85","author":"JK Nguyen","year":"2024","unstructured":"Nguyen JK, Harik LR, Klein EA et al (2024) Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. Histopathology 85:598\u2013613. https:\/\/doi.org\/10.1111\/his.15231","journal-title":"Histopathology"},{"key":"4571_CR15","doi-asserted-by":"publisher","unstructured":"Epstein JI, Allsbrook WC, Amin MB et al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228\u20131242. https:\/\/doi.org\/10.1097\/01.PAS.0000173646.99337.B1","DOI":"10.1097\/01.PAS.0000173646.99337.B1"},{"key":"4571_CR16","doi-asserted-by":"publisher","unstructured":"Epstein JI, Egevad L, Amin MB et al (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 40:244\u2013252. https:\/\/doi.org\/10.1097\/PAS.0000000000000530","DOI":"10.1097\/PAS.0000000000000530"},{"key":"4571_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/J.1464-410X.2012.11611.X","volume":"111","author":"PM Pierorazio","year":"2013","unstructured":"Pierorazio PM, Walsh PC, Partin AW, Epstein JI (2013) Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 111:753\u2013760. https:\/\/doi.org\/10.1111\/J.1464-410X.2012.11611.X","journal-title":"BJU Int"},{"key":"4571_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/PAS.0B013E3182217B79","volume":"35","author":"S Karram","year":"2011","unstructured":"Karram S, Trock BJ, Netto GJ, Epstein JI (2011) Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings. Am J Surg Pathol 35:1351\u20131355. https:\/\/doi.org\/10.1097\/PAS.0B013E3182217B79","journal-title":"Am J Surg Pathol"},{"key":"4571_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/S00428-020-03009-X","volume":"478","author":"M Lu","year":"2021","unstructured":"Lu M, Wu S, Wu CL (2021) Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review. Virchows Arch 478:383\u2013391. https:\/\/doi.org\/10.1007\/S00428-020-03009-X","journal-title":"Virchows Arch"},{"key":"4571_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/JAMAONCOL.2017.1879","volume":"4","author":"HD Patel","year":"2018","unstructured":"Patel HD, Tosoian JJ, Carter HB, Epstein JI (2018) Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group. JAMA Oncol 4:89\u201392. https:\/\/doi.org\/10.1001\/JAMAONCOL.2017.1879","journal-title":"JAMA Oncol"},{"key":"4571_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/HIS.12976","volume":"69","author":"CF Kweldam","year":"2016","unstructured":"Kweldam CF, Nieboer D, Algaba F et al (2016) Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists. Histopathology 69:441\u2013449. https:\/\/doi.org\/10.1111\/HIS.12976","journal-title":"Histopathology"},{"key":"4571_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/JNCCN.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ et al (2019) Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17:479\u2013505. https:\/\/doi.org\/10.6004\/JNCCN.2019.0023","journal-title":"J Natl Compr Canc Netw"},{"key":"4571_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/S00428-020-03003-3","volume":"478","author":"M Varma","year":"2021","unstructured":"Varma M, Shah RB, Williamson SR, Berney DM (2021) 2019 Gleason grading recommendations from ISUP and GUPS: broadly concordant but with significant differences. Virchows Arch 478:813\u2013815. https:\/\/doi.org\/10.1007\/S00428-020-03003-3","journal-title":"Virchows Arch"},{"key":"4571_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAP.0000000000000287","volume":"28","author":"SC Smith","year":"2021","unstructured":"Smith SC, Gandhi JS, Moch H et al (2021) Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists. Adv Anat Pathol 28:1\u20137. https:\/\/doi.org\/10.1097\/PAP.0000000000000287","journal-title":"Adv Anat Pathol"},{"key":"4571_CR25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0000000000000714","volume":"40","author":"ET Sadimin","year":"2016","unstructured":"Sadimin ET, Khani F, Diolombi M et al (2016) Interobserver Reproducibility of Percent Gleason Pattern 4 in Prostatic Adenocarcinoma on Prostate Biopsies. Am J Surg Pathol 40:1686\u20131692. https:\/\/doi.org\/10.1097\/PAS.0000000000000714","journal-title":"Am J Surg Pathol"},{"key":"4571_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/HIS.12008","volume":"62","author":"L Egevad","year":"2013","unstructured":"Egevad L, Ahmad AS, Algaba F et al (2013) Standardization of Gleason grading among 337 European pathologists. Histopathology 62:247\u2013256. https:\/\/doi.org\/10.1111\/HIS.12008","journal-title":"Histopathology"},{"key":"4571_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.juro.2011.03.115","volume":"186","author":"JK McKenney","year":"2011","unstructured":"McKenney JK, Simko J, Bonham M et al (2011) The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol 186:465\u2013469. https:\/\/doi.org\/10.1016\/j.juro.2011.03.115","journal-title":"J Urol"},{"key":"4571_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/S00428-020-02858-W","volume":"477","author":"L Egevad","year":"2020","unstructured":"Egevad L, Swanberg D, Delahunt B et al (2020) Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading. Virchows Arch 477:777\u2013786. https:\/\/doi.org\/10.1007\/S00428-020-02858-W","journal-title":"Virchows Arch"},{"key":"4571_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/his.14867","volume":"82","author":"L Egevad","year":"2023","unstructured":"Egevad L, Delahunt B, Iczkowski KA et al (2023) Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria. Histopathology 82:837\u2013845. https:\/\/doi.org\/10.1111\/his.14867","journal-title":"Histopathology"},{"key":"4571_CR30","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","volume":"45","author":"TH Van Der Kwast","year":"2021","unstructured":"Van Der Kwast TH, Van Leenders GJ, Berney DM et al (2021) ISUP Consensus Definition of Cribriform Pattern Prostate Cancer. Am J Surg Pathol 45:1118\u20131126. https:\/\/doi.org\/10.1097\/PAS.0000000000001728","journal-title":"Am J Surg Pathol"},{"key":"4571_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/MODPATHOL.2014.116","volume":"28","author":"CF Kweldam","year":"2015","unstructured":"Kweldam CF, Wildhagen MF, Steyerberg EW et al (2015) Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol 28:457\u2013464. https:\/\/doi.org\/10.1038\/MODPATHOL.2014.116","journal-title":"Mod Pathol"},{"key":"4571_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejca.2016.07.012","volume":"66","author":"CF Kweldam","year":"2016","unstructured":"Kweldam CF, K\u00fcmmerlin IP, Nieboer D et al (2016) Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma. Eur J Cancer 66:26\u201333. https:\/\/doi.org\/10.1016\/j.ejca.2016.07.012","journal-title":"Eur J Cancer"},{"key":"4571_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/HIS.13767","volume":"74","author":"CF Kweldam","year":"2019","unstructured":"Kweldam CF, van Leenders GJ, van der Kwast T (2019) Grading of prostate cancer: a work in progress. Histopathology 74:146\u2013160. https:\/\/doi.org\/10.1111\/HIS.13767","journal-title":"Histopathology"},{"key":"4571_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/ARPA.2020-0015-RA","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein JI, Amin MB, Fine SW et al (2021) The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Arch Pathol Lab Med 145:461\u2013493. https:\/\/doi.org\/10.5858\/ARPA.2020-0015-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4571_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00330-025-11603-3","volume":"36","author":"F Carletti","year":"2026","unstructured":"Carletti F, Maggi M, Fazekas T et al (2026) Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis. Eur Radiol 36:17\u201329. https:\/\/doi.org\/10.1007\/s00330-025-11603-3","journal-title":"Eur Radiol"},{"key":"4571_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/his.14658","volume":"80","author":"LL Rijstenberg","year":"2022","unstructured":"Rijstenberg LL, Hansum T, Kweldam CF et al (2022) Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies. Histopathology 80:1041\u20131049. https:\/\/doi.org\/10.1111\/his.14658","journal-title":"Histopathology"},{"key":"4571_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/his.15102","volume":"84","author":"NY Greenland","year":"2024","unstructured":"Greenland NY, Cowan JE, Stohr BA et al (2024) Large cribriform glands (>\u20090.25\u00a0mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology 84:614\u2013623. https:\/\/doi.org\/10.1111\/his.15102","journal-title":"Histopathology"},{"key":"4571_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/PAS.0000000000000736","volume":"40","author":"JK McKenney","year":"2016","unstructured":"McKenney JK, Wei W, Hawley S et al (2016) Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized. Am J Surg Pathol 40:1439\u20131456. https:\/\/doi.org\/10.1097\/PAS.0000000000000736","journal-title":"Am J Surg Pathol"},{"key":"4571_CR39","doi-asserted-by":"publisher","unstructured":"Nguyen JK, Li J, Ding CKC et al (2025) Correlation of large cribriform carcinoma and unfavorable histology with other Gleason pattern 4 subtypes: A proof-of-principle study evaluating 485 radical prostatectomy specimens with proposal for the concept of borderline histology. Ann Diagn Pathol 75. https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152427","DOI":"10.1016\/j.anndiagpath.2024.152427"},{"key":"4571_CR40","doi-asserted-by":"publisher","unstructured":"Shee K, Cowan JE, Ding CKC et al (2025) Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2025.04.027","DOI":"10.1016\/j.euf.2025.04.027"},{"key":"4571_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/HIS.14060","volume":"76","author":"L Egevad","year":"2020","unstructured":"Egevad L, Str\u00f6m P, Kartasalo K et al (2020) The utility of artificial intelligence in the assessment of prostate pathology. Histopathology 76:790\u2013792. https:\/\/doi.org\/10.1111\/HIS.14060","journal-title":"Histopathology"},{"key":"4571_CR42","doi-asserted-by":"publisher","first-page":"26286","DOI":"10.1038\/srep26286","volume":"6","author":"G Litjens","year":"2016","unstructured":"Litjens G, S\u00e1nchez CI, Timofeeva N et al (2016) Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci Rep 6:26286. https:\/\/doi.org\/10.1038\/srep26286","journal-title":"Sci Rep"},{"key":"4571_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41391-023-00673-3","volume":"26","author":"A Morozov","year":"2023","unstructured":"Morozov A, Taratkin M, Bazarkin A et al (2023) A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. Prostate Cancer Prostatic Dis 26:681\u2013692. https:\/\/doi.org\/10.1038\/s41391-023-00673-3","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4571_CR44","unstructured":"Food and Drug Administration (FDA) (2021) FDA Authorizes Software that Can Help Identify Prostate Cancer. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-software-can-help-identify-prostate-cancer"},{"key":"4571_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1053\/HUPA.2001.21134","volume":"32","author":"WC Allsbrook","year":"2001","unstructured":"Allsbrook WC, Mangold KA, Johnson MH et al (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol 32:74\u201380. https:\/\/doi.org\/10.1053\/HUPA.2001.21134","journal-title":"Hum Pathol"},{"key":"4571_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","volume":"21","author":"P Str\u00f6m","year":"2020","unstructured":"Str\u00f6m P, Kartasalo K, Olsson H et al (2020) Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol 21:222\u2013232. https:\/\/doi.org\/10.1016\/S1470-2045(19)30738-7","journal-title":"Lancet Oncol"},{"key":"4571_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten W, Pinckaers H, van Boven H et al (2020) Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol 21:233\u2013241. https:\/\/doi.org\/10.1016\/S1470-2045(19)30739-9","journal-title":"Lancet Oncol"},{"key":"4571_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/S41591-021-01620-2","volume":"28","author":"W Bulten","year":"2022","unstructured":"Bulten W, Kartasalo K, Chen PHC et al (2022) Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat Med 28:154\u2013163. https:\/\/doi.org\/10.1038\/S41591-021-01620-2","journal-title":"Nat Med"},{"key":"4571_CR49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/S41379-020-0640-Y","volume":"34","author":"W Bulten","year":"2021","unstructured":"Bulten W, Balkenhol M, Belinga JJA et al (2021) Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod Pathol 34:660\u2013671. https:\/\/doi.org\/10.1038\/S41379-020-0640-Y","journal-title":"Mod Pathol"},{"key":"4571_CR50","doi-asserted-by":"publisher","unstructured":"Ambrosini P, Hollemans E, Kweldam CF et al (2020) Automated detection of cribriform growth patterns in prostate histology images. Sci Rep 10. https:\/\/doi.org\/10.1038\/s41598-020-71942-7","DOI":"10.1038\/s41598-020-71942-7"},{"key":"4571_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.euf.2021.04.016","volume":"7","author":"P Leo","year":"2021","unstructured":"Leo P, Chandramouli S, Farr\u00e9 X et al (2021) Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2. Eur Urol Focus 7:722\u2013732. https:\/\/doi.org\/10.1016\/j.euf.2021.04.016","journal-title":"Eur Urol Focus"},{"key":"4571_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s44303-023-00005-z","volume":"2","author":"O Eminaga","year":"2024","unstructured":"Eminaga O, Saad F, Tian Z et al (2024) Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology images. Npj imaging 2:6. https:\/\/doi.org\/10.1038\/s44303-023-00005-z","journal-title":"Npj imaging"},{"key":"4571_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.eururo.2025.08.018","volume":"89","author":"E Cha","year":"2026","unstructured":"Cha E, Lin Z, Lu J et al (2026) Histopathology-based Artificial Intelligence Algorithms for the Prediction of Prostate Cancer Metastasis After Radical Prostatectomy. Eur Urol 89:140\u2013148. https:\/\/doi.org\/10.1016\/j.eururo.2025.08.018","journal-title":"Eur Urol"},{"key":"4571_CR54","unstructured":"The LEOPARD Challenge. https:\/\/leopard.grand-challenge.org\/"},{"key":"4571_CR55","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/bju.70164","volume":"137","author":"CM de la Calle","year":"2026","unstructured":"de la Calle CM, Baras AS, Lotan TL (2026) Digital pathology-based artificial intelligence algorithms in prostate cancer: inside the \u2018black box\u2019. BJU Int 137:596\u2013604. https:\/\/doi.org\/10.1111\/bju.70164","journal-title":"BJU Int"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04571-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:26:46Z","timestamp":1778552806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":55,"alternative-id":["4571"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04571-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}